GENEVA, June 10 -- PHARIS BIOTEC GMBH (Feodor-Lynen Str. 3130625 Hannover) filed a patent application (PCT/EP2024/084149) for "ALB408-423 PEPTIDES FOR USE IN THE TREATMENT OF CANCER IN COMBINATION WITH RADIOTHERAPY" on Nov 29, 2024. With publication no. WO/2025/114560, the details related to the patent application was published on Jun 05, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): FORSSMANN, Wolf-Georg (c/o Pharis Biotec GmbHFeodor-Lynen Str. 3130625 Hannover)
Abstract:
A peptide for use in treating and/or preventing cancer, especially sarcoma, in combination with radiotherapy, espec...